Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Cencora, Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinge...

Analysts Conflicted on These Healthcare Names: Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinger (SDGR)

Cencora ( ($COR) ) has provided an update. In the fiscal third quarter ended June 30, 2026, Cencora reported revenue of $84.8 billion, up 5.1 perce...

Cencora Raises 2026 EPS Outlook After Strong Quarter

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beam Therapeutics (BEAM), Rhythm Pharmaceuticals (RY...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Core Scientific Inc received a Hold rating and price target from KBW analyst Christopher Mcgratty today. Mcgratty covers the Financial sector, focu...

Core Scientific Inc (CORZ) was downgraded to a Hold Rating at KBW

Analysts are intrested in these 5 stocks: ( ($OTLK) ), ( ($HBAN) ), ( ($CORT) ), ( ($CAPR) ) and ( ($GOSS) ). Here is a breakdown of their recent


OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

Analysts are intrested in these 5 stocks: ( ($CIFR) ), ( ($WSM) ), ( ($BWXT) ), ( ($ACI) ) and ( ($CORZ) ). Here is a breakdown of their recent


Cipher, HIVE, WULF, WSM, BWXT Trending With Analysts

In a report released yesterday, from Canaccord Genuity reiterated a Buy rating on Ecora Royalties PLC, with a price target of p195.00. In a report ...

Ecora Royalties PLC (ECOR) Receives a Buy from Canaccord Genuity

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viking Therapeutics (VKTX), AbbVie (ABBV) and Cenc...

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), AbbVie (ABBV) and Cencora (COR)

Core Scientific Inc received a Buy rating and a $33.00 price target from Freedom Capital Markets analyst Paul Meeks today. According to TipRanks, M...

Positive Report for Core Scientific Inc (CORZ) from Freedom Capital Markets

Piper Sandler analyst David Amsellem reiterated a Buy rating on Corcept Therapeutics today and set a price target of $165.00. According to TipRanks...

Piper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)

Procore Technologies ( ($PCOR) ) has shared an announcement. On July 27, 2026, Procore Technologies entered into a definitive agreement to acquire ...

Procore to Acquire DroneDeploy, Expanding AI Capabilities

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Core Scientific Inc (CORZ) and CommVault Systems (CV...

Analysts Offer Insights on Technology Companies: Core Scientific Inc (CORZ) and CommVault Systems (CVLT)

AMD stock dropped on Tuesday even after the company announced a new MSIT partnership.


AMD Stock Dips Despite a New MSIT Partnership

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Zscaler (ZS) and Procore Technologies (PCOR) with bu...

Analysts Offer Insights on Technology Companies: Zscaler (ZS) and Procore Technologies (PCOR)

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Procore Technologies (PCOR), STMicroelectronics (STM...

Analysts’ Top Technology Picks: Procore Technologies (PCOR), STMicroelectronics (STM)

Analysts fell to the sidelines weighing in on Cencora (COR), Avita Medical (RCEL) and Tempus AI, Inc. Class A (TEM) with neutral ratings, indicatin...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	COR	$320.46	-1.40%	1.56M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	COR	$320.46	-1.4%	1.56M
3
4
5
6

COR

COR

Get Cencora, Inc. Data in Excel

Get Cencora, Inc. Data in Excel